Auto Keratometer Market Share

North American Market Statistics

North America region in auto keratometer market is poised to dominate over 42% revenue share by 2036. The region’s auto keratometer sector is thriving, because of the rising frequency of eye problems in this region. According to the American Optometric Association, over 40% of Americans suffer from myopia, and the percentage is startlingly rising, particularly among youngsters in school.

In fact, according to recent statistics from the American Optometric Association's (AOA) American Eye-Q study, one in four parents had a kid with myopia (commonly known as "nearsightedness"), and over 75% of children with myopia received their diagnosis between the ages of 3 and 12.

The auto keratometer market has expanded in the U.S. as a result of the rising need for ophthalmological treatments and diagnostic techniques. The most recent development in imaging technology is an optical coherence tomography scan, or OCT scan. This diagnostic method, which is similar to ultrasound, uses light instead of sound waves to provide better-quality images of the structural layers of the retina.

The Canadian auto keratometers development mainly lies in the rising investment in healthcare infrastructure. The largest healthcare investment in over 20 years was made by the Canadian federal government in the 2023 budget, which included a USD 46.2 billion increase in financing for provinces and territories.

APAC Market Analysis

APAC region in auto keratometer market is poised to register around 6.2% growth from 2024 to 2036,  owing to the increasing population of patients suffering from astigmatism conditions.

According to the International Myopia Institute, research indicates that in recent decades, the number of instances of myopia in Asian nations has rapidly grown, along with greater expectations placed on young children about their education. About 80–90% of high school graduates in several East Asian nations suffer from myopia, a serious public health problem. Of them, 10–20% have sight-threatening pathologic myopia.

Auto keratometers are especially in actual demand in China, driven by the rising population and the rising number of eye patients in this country. China's population is estimated to have decreased from 1.412 billion in the 2020 census to 1.409 billion in 2023.

In Korea, auto keratometers will encounter massive growth because the country is a hotspot for myopia patients. Moreover, in Korea, the corresponding rates of myopia and high myopia were 6.9% and 65.4%, respectively.

The auto keratometers sector will also be huge in Japan due to the rising use of keratometry devices for Myopia and Presbyopia treatment across different hospitals and clinics along with the rising prevalence of hospitals in Japan. Japan has one of the greatest densities and total populations. In Japan, hospitals that are not publicly funded are primarily privately owned by medical firms.